Neanderthals and Denisovans are extinct groups of hominins that separated from each other more than 390,000 years ago 1,2 . Here we present the genome of 'Denisova 11' , a bone fragment from Denisova Cave (Russia) 3 and show that it comes from an individual who had a Neanderthal mother and a Denisovan father. The father, whose genome bears traces of Neanderthal ancestry, came from a population related to a later Denisovan found in the cave 4-6 . The mother came from a population more closely related to Neanderthals who lived later in Europe 2,7 than to an earlier Neanderthal found in Denisova Cave 8 , suggesting that migrations of Neanderthals between eastern and western Eurasia occurred sometime after 120,000 years ago.
present-day human DNA fragments constitute at most 1.7% of the data (Supplementary Information 2).
To determine from which hominin group Denisova 11 originated, we compared the proportions of DNA fragments that match derived alleles from a Neanderthal genome (' Altai Neanderthal' , also known as 'Denisova 5') or a Denisovan genome (Denisova 3), both determined from bones discovered in Denisova Cave 6, 8 , as well as from a presentday African genome (Mbuti) 6 ( Supplementary Information 4) . At informative sites 1 , 38.6% of fragments from Denisova 11 carried alleles matching the Neanderthal genome and 42.3% carried alleles matching the Denisovan genome ( Fig. 2a ), suggesting that both archaic groups contributed to the ancestry of Denisova 11 to approximately equal extents ( Supplementary Information 4) . Approximately equal proportions of Neanderthal-like and Denisovan-like alleles are found in each of the ten DNA libraries originating from Denisova 11 but not in libraries from other projects that were prepared, sequenced and processed in parallel, which excludes an accidental mixing of DNA in the laboratory or a systematic error in data processing ( Supplementary Information 3) .
To estimate the heterozygosity of Denisova 11, we restrict the analysis to transversion polymorphisms to prevent deamination-derived substitutions from inflating the estimates, and find 3.7 transversions per 10,000 autosomal base pairs. This is over four times higher than the heterozygosity of the two Neanderthal (Altai Neanderthal and 'Vindija 33.19') and one Denisovan (Denisova 3) genomes sequenced to date, and similar to the heterozygosity seen in present-day Africans. In fact, the heterozygosity of Denisova 11 is similar to what would be expected if this individual carried one set of chromosomes of Neanderthal origin and one of Denisovan origin, as estimated from the number of differences between randomly sampled DNA fragments from either the Vindija 33.19 or the Altai Neanderthal genome and the Denisova 3 genome ( Fig. 2b and Supplementary Information 5).
Denisova 11 could have had approximately equal amounts of Neanderthal and Denisovan ancestry because she belonged to a population with mixed Neanderthal and Denisovan ancestry, or because her parents were each from one of these two groups. To determine which of these two scenarios fits the data best, we considered sites at which the genomes of the Altai Neanderthal and Denisova 3 carry a transversion difference in a homozygous form. At each of these sites, we recorded the alleles carried by two randomly drawn DNA fragments from Denisova 11. Note that in 50% of cases, both fragments will come from the same chromosome, making 50% of heterozygous sites appear homozygous. As a consequence, the expected proportion of apparent heterozygous sites is 50% for a first-generation (F 1 ) offspring, whereas it is 25% in a population at Hardy-Weinberg equilibrium with mixed ancestry in equal proportions (Supplementary Information 6). We find that in 43.5% of cases, one fragment from Denisova 11 matches the Neanderthal genome and the other matches the Denisovan genome, whereas in 27.3% and 29.2% of cases both fragments match the state Letter reSeArCH seen in the Neanderthal or the Denisovan genome, respectively ( Fig. 2c ). For comparison, when a low-coverage Neanderthal genome ('Goyet Q56-1') 7 is analysed in the same way, the two fragments match different states in 2.1% of cases, while they both match the Neanderthal state in 90.3% of cases and the Denisovan state in 7.5% of cases ( Fig. 2c) .
Obviously, the Altai Neanderthal and Denisova 3 are unlikely to be identical to the genomes of the individuals that contributed ancestry to Denisova 11. To take this into account, we used coalescent simulations to estimate the expected proportions of DNA fragments matching a Neanderthal or a Denisovan genome in populations with demographic histories similar to those of the Altai Neanderthal and Denisova 3 (Supplementary Information 6). The proportion of cases in which one of the two DNA fragments sampled from Denisova 11 matches the Neanderthal state and the other the Denisovan state fits the expectation for an F 1 Neanderthal-Denisovan offspring, but not an offspring of two F 1 individuals, an offspring of an F 1 parent and a Neanderthal or a Denisovan parent, nor an individual from a population of mixed ancestry at Hardy-Weinberg equilibrium (Extended Data Fig. 2 and Supplementary Information 6). We conclude that Denisova 11 did not originate from a population carrying equal proportions of Neanderthal and Denisovan ancestry. Rather, she was the offspring of a Neanderthal mother, who contributed her mtDNA, and a Denisovan father.
We next plotted the distribution of sites across the genome, for which Denisova 11 carries an allele matching the Altai Neanderthal genome and a different allele matching the Denisova 3 genome. Such sites are distributed largely uniformly ( Fig. 3 ), as would be expected for an F 1 offspring of Neanderthal and Denisovan parents. To explore the ancestry of the parents of Denisova 11, we looked for regions in the genome that deviate from a pattern consistent with Denisova 11 being an F 1 offspring (Extended Data Fig. 3 Letter reSeArCH which are homozygous for Neanderthal ancestry. This suggests that the Denisovan father of Denisova 11 had some Neanderthal ancestry. Given conservative estimates of the size and number of these regions, it is likely that there was more than one Neanderthal ancestor in his genealogy, possibly as far back as 300-600 generations before his lifetime ( Supplementary Information 7) . Notably, the heterozygosity in the regions of Neanderthal ancestry in Denisova 11 is higher than in the same regions in the genomes of Vindija 33.19 or the Altai Neanderthal, suggesting that the Neanderthals that contributed to the ancestry of Denisova 11's father were from a different population than her mother (Supplementary Information 5). To explore how the mother of Denisova 11 was related to the two Neanderthals that have been sequenced to high coverage to date, we evaluated the proportions of fragments from Denisova 11 that match derived alleles from either of these two Neanderthal genomes. Denisova 11 shares derived alleles seen in the Altai Neanderthal genome in 12.4% of cases and those present in the Vindija 33.19 genome in 19.6% of cases, showing that the Neanderthal mother of Denisova 11 came from a population that was more closely related to Vindija 33.19 than to the Altai Neanderthal ( Supplementary Information 8) . We estimate the population split times of Denisova 11's Neanderthal mother from the ancestors of the Altai Neanderthal to approximately 20,000 years (20 kyr) before the time when the Altai Neanderthal lived, and her split time from the ancestors of Vindija 33.19 to around 40 kyr before Vindija 33.19. The population split between the Denisovan father of Denisova 11 and Denisova 3 is estimated to approximately 7 kyr before the latter individual (Supplementary Information 8). In Fig. 4 , we present a population scenario that is compatible with these observations as well as with the population split times and molecular estimates of the ages of the three high-coverage archaic genomes 2 . We caution that the age estimates are associated with uncertainties, for example, regarding demography, mutation rates and generation times, and note that additional gene flow events are likely to have affected the population split times. Nevertheless, that a Neanderthal in Siberia who lived approximately 90 ka shared more alleles with Neanderthals who lived at least 20 kyr later in Europe 2,7 than with an earlier Neanderthal from the same cave 8 . Markers indicate the means of these estimates, error bars indicate 95% confidence intervals based on block jackknife resampling across the genome (n = 523 blocks). Note that the confidence intervals do not take the uncertainty with respect to population size, mutation rates or generation times into account. Ages before present are based on a human-chimpanzee divergence of 13 million years 22, 29 . The arrow indicates Neanderthal gene flow into Denisovans.
Letter reSeArCH sometime after 90 ka or that western Neanderthals spread to Siberia before that time and partially replaced the local population. These two non-mutually exclusive hypotheses could be tested by sequencing the genomes of early Neanderthals from Western Europe.
In conclusion, the genome of Denisova 11 provides direct evidence for genetic mixture between Neanderthals and Denisovans on at least two occasions: once between her Neanderthal mother and her Denisovan father, and at least once in the ancestry of her Denisovan father. Therefore, of the six individuals from Denisova Cave from whom nuclear DNA is available 5, 6, 8, 11, 12 , two (Denisova 3 and Denisova 11) show evidence of gene flow between Neanderthals and Denisovans. We note that of the three genomes [21] [22] [23] [24] retrieved from modern humans who lived at a time when Neanderthals were present in Eurasia (that is, approximately 40 ka or earlier) 9 , one individual-'Oase 1'-had a Neanderthal ancestor four to six generations back in his family tree 23 .
It is notable that one direct offspring of a Neanderthal and a Denisovan (Denisova 11) and one modern human with a close Neanderthal relative (Oase 1) have been identified among the few individuals from whom DNA has been retrieved and who lived at the time of overlap of these groups (Fig. 1 ). In conjunction with the presence of Neanderthal and Denisovan DNA in ancient and present-day people 2, 5, 8, 13, 16, 17, [25] [26] [27] , this suggests that mixing among archaic and modern hominin groups may have been frequent when they met. However, Neanderthals inhabited western Eurasia 10 whereas Denisovans inhabited yet unknown parts of eastern Eurasia 5,17 . Thus, their zones of overlap may have been restricted in space and time. This, as well as possibly reduced fitness of individuals of mixed ancestry, may explain why Neanderthals and Denisovans remained genetically distinct. By contrast, the spread of modern humans across Eurasia after around 60,000 years ago may have allowed repeated interactions with archaic groups over a wider spatial range. Admixture between them may have resulted in archaic populations becoming partly absorbed into what were probably larger modern human populations 6, 8 .
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0455-x. Table 1 . Bone powder was removed from the specimen using disposable sterile dentistry drills after the removal of a thin layer of surface material. Six samples were collected, each consisting of approximately 30 mg of bone powder. Because a previous analysis of the bone revealed that it is contaminated with present-day human DNA 3 , each sample of bone powder was incubated with 1 ml 0.5% sodium hypochlorite solution as previously described 19 and as indicated in Extended Data Table 1 , to reduce the amounts of present-day human and microbial DNA 7, 19 . Residual sodium hypochlorite was removed by three consecutive 3-min washes with 1 ml water 19 . One extraction negative control (no powder) was included in each set of extractions. DNA extraction and DNA library preparation. DNA was extracted using silica columns 18 as previously described 19 , and eluted in 50 μl 10 mM Tris-HCl, 1 mM EDTA, 0.05% Tween-20, pH 8.0. Subsequently, 10 μl of each DNA extract (including the extraction negative controls) were used to prepare single-stranded DNA libraries as previously described 19, 20 . A library preparation negative control was included in every experiment. Two additional 5-μl aliquots from extracts E3652 and E3655 were used to generate additional libraries (library preparation setup C in Extended Data Table 1 ), resulting in a total of 10 DNA libraries. The number of DNA molecules in the libraries was estimated by digital droplet PCR 30 or quantitative PCR 20 . Each library was amplified to the plateau while incorporating a pair of unique indexes 31 using 1 μM primers 19, 31 and AccuPrime Pfx DNA polymerase (Life Technologies) 32 . Amplification products were purified using the MinElute PCR purification kit (Qiagen) or SPRI technology 33 on a Bravo NGS workstation (Agilent Technologies) as previously described 34 . Indexed DNA libraries were pooled with libraries from other projects. Heteroduplices, which confound DNA separation and concentration measurements in chromatography, were removed from the pools by single cycle amplification using Herculase II Fusion DNA polymerase (Agilent Technologies) 32 with primers IS5 and IS6 35 . Prior to deeper sequencing of libraries R5507, R5509, R9880, R9881, R9882, R9883 and R9873, heteroduplices were removed from each library separately. The concentration of DNA in each pool or each individual library, respectively, was determined using the electrophoresis system implemented on the DNA-1000 chip (Agilent Technologies). Sequencing and data processing. Sequencing was performed on Illumina platforms (MiSeq or HiSeq 2500) using 76-cycle paired-end runs adapted to double-indexed libraries 31 . Bases were called using Bustard (Illumina). Adaptor sequences were trimmed and overlapping paired-end reads were merged into single sequences using leeHom 36 . Demultiplexing was carried out using jivebunny 7 . Sequences generated from a given library were merged using SAMtools 37 and aligned to the human reference genome (hg19/GRCh37) with the decoy sequences as previously described 2 using BWA 38 with parameters adjusted to ancient DNA 6 . PCR duplicates were collapsed using bam-rmdup (https://bitbucket.org/ustenzel/ biohazard) and DNA fragments of length ≥35 bases that mapped within regions of unique mappability (Map35_100% from a previous publication 8 ) with a mapping quality of 25 or higher 7 were used for analyses. Further filtering criteria used for certain analyses are described in the Supplementary Information. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Code availability. The computer code used for simulations is included in Supplementary Information 6. Data availability. Sequences generated from Denisova 11 have been deposited in the European Nucleotide Archive under study accession number PRJEB24663. Corresponding author(s): Viviane Slon; Svante Pääbo Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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MEthodS
Sampling and pre-treatment of bone powder. An overview of the laboratory experiments is shown in Extended Data
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Experimental design 1. Sample size
Describe how sample size was determined.
The sample size is 1, as we are determining the genome of a single individual. For comparisons with other archaic genomes, all available high-coverage Neandertal and Denisovan genomes (n=3) were used.
Data exclusions
Describe any data exclusions.
Sequencing data excluded based on pre-established criteria: sequences that did not map to the human genome, sequences that were shorter than 35 bases, sequences mapping with a low mapping quality or within regions of low mappability -all of which were excluded to avoid using sequences that were not endogenous to the individual sequenced.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
The bone fragment was sampled on three different occasions, on different areas of the specimen (total of six samples of bone powder). Six DNA extracts were prepared on three occasions, and ten DNA libraries were generated in three different experiments. We show in SI 3 that the results are stable across all different libraries. To allow the reproducibility of the analyses, all filtering steps and the comparative data used are detailed in the Methods section and the supplementary information; and the sequencing data generated here has been deposited in the European Nucleotide Archive.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups. This is not relevant for our study as we determined the genome of a single individual, therefore there were no experimental groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not relevant for our study, as this is the genome of a single individual. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
The sequencing data generated from the Denisova 11 bone fragment and the CT scans of the specimen are publicly available. Requests for further sampling of the bone fragment should be addressed to the Institute of Archaeology and Ethnography of the Russian Academy of Sciences.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). c. Report whether the cell lines were tested for mycoplasma contamination.
No eukaryotic cell lines were used.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
